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As part of an ongoing effort to develop PET imaging agents for use in tumor 
detection andor to monitor response to chemotherapy, several 2'-[F-18]fluoro-2'- 
deoxy-P-D-arabinofuranosyl nucleosides were prepared: l a  (FAU), l b  (FMAU) and 
l c  (FIAU). These analogs of thymidine are substrates for thymidine kinase, a key 
enzyme of DNA synthesis. 
Thymidine l a  R=-H 
l b  R=-CH3 
IC R=-I 
The overall synthetic approach to these compounds is based on that published by 
Howell et a1 (1, 2) for the unlabeIIed compounds (Scheme I). initially, the 
tribenzoylated [F-l8]fluorinated arabinose 4 was prepared in low yield (10 - 12% 
decay corrected) from the sulfonyl imidazole 2 with [F-18Jfluoride and KHF2 in 
butanediol at 160°C for 20 min. Use of the triflate 3, however, with kryptofix- 
assisted radiofluorination, proved to be a more efficient approach to 4. After 
examining a variety of polar, aprotic solvents (MeCN, DMF, DMSO) and reaction 
temperatures for the nucleophilic radiofluorination of the triflate 3, reaction 
. conditions were developed ([F-l8]fluoride/KRP/K2C03 in DMF for 5 A n  at 
15OOC) that consistently provide 4 in radiochemical yields of 70 - 80% (decay 
corrected). Following the radiofluorination reaction, the DMF is evaporated and the 
residue, dissolved in methylene chloride, is passed through a small silica gel column 
to remove the kryptofix and any unreacted [F-l8]fluoride. The product is then 
eluted from the column with a :mall volume of methylene chloride. 
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The protected [F-181fluorinated arabinose 4 is converted to the dibenzoyl bromide 5 
in excellent radiochemical yield (80 - 90% corr) by treatment with HBr/AcOH in 
CH2C12 for 10 min at 125°C. Following the bromination, evaporation of the 
CH2C12 at 125°C and final removal of any residual traces of HBr and acetic acid 
with the aid of a toluene azeotrope provides 5 as a dark oil ready for conversion to a 
number of protected arabinofuranosyl nucleoside analogs. 
Scheme 1 
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6P 6a 
\ 
Reaction Conditions: a) (with 2) [F-I8]fluoride, KHF2, in butanediol, 160°C for 20 min; b) (with 
3) [F-I8]fluoride, KRP 2.2.2, K2CO3, in DMF, 150°C for 5 min; c) HBr/AcOH in CH2C12. 125°C 
for I0 min; d) bis(Me3Si)uracil (a) or bis(Me3Si)thymine (b) or bis(Me3Si)-5-iodouracil (c) in 
CHC13, 150°C for 30 min; e) NaOMelMeOH in MeCN, 20°C for 10 min, followed by semi-prep 
HPLC (C-18, 10% EtOH). . 
Condensation of 5 with several bis(trimethylsi1yl)pyrimidines give the 
corresponding dibenzoyl arabino nucleosides 6 a,b,c as a mixture of the a a n d  p 
isomers in excellent radiochemical yields, The ratio of fl to a is dependent on the 
polarity of the reaction solvent. In line with a published report (2), when the 
condensation of 5 with a siIyIated uracil is carried out in MeCN (at 150°C for 30 
min), the ratio of the desired /3 isomer to the unwanted a isomer is approximately 3 
to 1. Under similar conditions in methylene chloride, this ratio increases to 4 to 1, 
and in chloroform (the solvent currently being employed) this ratio is approximately 
8 to 1. Following the condensation reaction, 6 (as an isomeric mixture) is isolated 
by passing the reaction mixture through a small silica gel column, washing the 
column with methylene chloride and eluting the product with chloroform containing 
1% ethanol. The chloroform is then removed by evaporation and crude 6 is 
dissolved in MeCN for the final deprotection reaction. 
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The benzoyl groups of the isomeric mixture 6 are cleanly removed by treatment with 
sodium methoxide (0.5M in MeOH) in MeCN (20°C for 10 min) to give, in excellent 
yield (80 - 90% corr), the corresponding mixture of cc and p isomers of 1. The 
desired p isomer is then isolated by semi-prep HPLC (C-18, 10% EtOH) in a decay- 
corrected overall radiochemical yield of 30 - 40% from [F-181fluoride. 
Each of these compounds have been prepared several times for initial imaging 
studies. In a typical synthesis, approximately 20 mCi of labelled product is obtained 
starting from approximately 200 mCi of [F-1 Slfluoride. Currently, the synthetic 
sequence takes a total of 3.5 hours, owing primarily to the time required for the 
bromination and condensation reactions. Efforts are currently underway to reduce 
the overall synthesis time and complexity by exploring alternative routes from 4 to 6. 
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